The United Laboratories International Holdings (HKG:3933) said its subsidiary, Zhuhai United Laboratories, received approval from China's National Medical Products Administration for its Polyvinyl alcohol eye drops (1.4%).
The single-dose formulation treats dry eye syndrome and related symptoms, including dryness, foreign body sensation, and eye fatigue, according to a Friday filing with the Hong Kong bourse.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.